-
Recent Posts
- Two Major Anti-AIDS Initiatives Launched At WEF Davos To Eradicate New HIV Infection in Children Within Four Years
- Are People With Low CD4s Getting Left Behind in Cure Research?
- New Studies Under Way of Sangamo’s Possible ‘Functional Cure’ Gene Therapy
- I’m Here for the New Year
- Ron Paul, Chris Wallace Need AIDS Education
Recent Comments
Archives
Categories
Category Archives: Health News
Animal Studies Suggest Anti-Reservoir Drugs May Help ‘Functionally Cure’ HIV
Drugs targeting HIV reservoirs in the body may result in spontaneous control of viral replication, in the absence of antiretroviral (ARV) therapy, according to a new study involving 18 monkeys conducted by Andrea Savarino, MD, PhD, of the Istituto Superiore … Continue reading
Complete One-Pill, Once-Daily Prezista-Based HIV Regimen Enters Development
Tibotec Therapeutics—the research and development division of Janssen Pharmaceuticals—has entered yet another agreement with Gilead Sciences to develop a fixed-dose combination (FDC) tablet. Now, according to a November 15 press release, the companies will develop a complete FDC regimen containing … Continue reading
Powerful HIV Inhibitor makes virus mutation ‘nearly impossible’
Washington: US scientists have created an inhibitor using a combination of two drugs to help prevent HIV virus from being transmitted. The inhibitor, a novel combination of two existing drugs, has a strength that ranges from several times better than … Continue reading
Changes to Your Body (Lipodystrophy & Wasting)
Ever since AIDS was first documented in the early 1980′s, one of the scariest and frustrating experiences for people living with HIV has been changes they experience in their body weight, size, and shape. For the first 15 years of … Continue reading
Cohort Study: No AIDS-Free Survival Benefit to Starting HIV Treatment at CD4s of 500 or More
Starting antiretroviral (ARV) therapy with a CD4 count above 500 doesn’t decrease the risk of AIDS or death from any cause, according to a new report from a large cohort study published in the September 26 issue of Archives of … Continue reading
HIV vaccine passes phase 1 trial
The Daily Telegraph reported that a “vaccine could reduce HIV to ‘minor infection’”. The news story reports on a phase I clinical trial that assessed the safety of a new HIV vaccine in a small group of people in Spain. … Continue reading
Life Expectancy With HIV Increases Dramatically
A 20-year-old HIV-positive person starting antiretroviral (ARV) therapy today can expect to live, on average, to the age of 69, according to new calculations published July 26 in The Lancet. The study authors say this is a life expectancy increase … Continue reading
HIV Treatment Outcomes Poorer in Adolescents and Young Adults
Adolescents and young adults appear less likely to benefit from antiretroviral therapy compared with adults, according to a small Northwestern University Feinberg School of Medicine study published ahead of print by the Journal of Acquired Immune Deficiency Syndromes. Future studies … Continue reading
“Remarkable” Treatment Outcomes in Urban HIV Clinic
Very high rates of retention in care and undetectable viral loads are possible in U.S. clinics providing care for disenfranchised people living with HIV in urban centers, according to a new study and accompanying editorial published online ahead of print … Continue reading
Posted in Health News
Leave a comment
Five-Year Follow-Up: Isentress Comparable to Sustiva
by Tim Horn Merck’s integrase inhibitor Isentress (raltegravir) works just as well as mainstay therapy efavirenz (found in Sustiva and Atripla) in HIV-positive individuals starting treatment for the first time, according to final five-year follow-up results from a Phase II … Continue reading
Posted in Health News
Leave a comment